Xiong Youxiang – Trademark Portfolio

Entity Type: 01

Xiong Youxiang owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ASSOYEZ, ECRIVEZ, and CANESERT. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 25 (Clothing) and Class 28 (Toys & Sporting Goods). Headquartered in Hubei Province.

403,Zhongzi Company of Jiangjun Road

Macheng City

Hubei Province 438300 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ASSOYEZ
ASSOYEZ
Registered 2020
CANESERT
CANESERT
Registered 2020
ECRIVEZ
ECRIVEZ
Registered 2020

Trademark Classifications

Xiong Youxiang's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Xiong Youxiang have?

Xiong Youxiang has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Xiong Youxiang file in?

Xiong Youxiang files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 28 (Toys & Sporting Goods), Class 12 (Vehicles). Class 25 covers clothing, footwear, headgear.

What are Xiong Youxiang's most well-known trademarks?

Xiong Youxiang's registered trademark portfolio includes well-known marks such as ASSOYEZ, ECRIVEZ, and CANESERT. These are among 3 currently registered trademarks in the portfolio.

What is Xiong Youxiang's trademark registration success rate?

Xiong Youxiang has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.